Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Procrastinating? Eat the frog, don’t chase the squirrels
On the metal wall in front of my desk, I’ve magnetically fastened a famous recommendation from Mark Twain. “Eat a live frog first thing in the morning and nothing worse will happen to you the rest of the day,” the humorist from Missouri wrote. Though it can become an aspiration rather than a rule,…
KCultivator Q&A: ‘Fashionpreneur’ Jordan Williams on starting with nothing but his smile
Editor’s note: KCultivators is a lighthearted profile series to highlight people who are meaningfully enriching Kansas City’s entrepreneurial ecosystem. Check out our features on Plexpod founder Gerald Smith, innovation coach Diana Kander, Victor & Penny’s Erin McGrane, SEED Law’s Adrienne Haynes, Code Koalas’ Robert Manigold, Prep-KC CEO Susan Wally and community builder Donald Carter. Jordan…
KC designers put streetwear innovation, culture on Kritiq runway (Photos)
Fashion entrepreneurs at Sunday night’s Kritiq fashion show shared many of the same struggles on their ways to the runway, Mark Launiu said. “One of our designers here was asked, ‘What’s your inspiration?’ And I think a lot of us can relate,” said Launiu, co-founder at MADE Urban Apparel and lead organizer of the event.…
Tax bill guts historic tax credits used to rehab Westport Commons, Kemper, lofts
Plexpod Westport Commons wouldn’t exist without the historic tax credits used to make the massive renovation and preservation project financially feasible, said developer Butch Rigby. A GOP-led tax reform bill introduced this month to simplify the tax code, however, would eliminate the Reagan-era tax credit program, which provides a 20 percent federal tax credit for…